%0 Journal Article %1 fogarty_meningococcal_1997 %A Fogarty, I %A Cafferkey, M T %A Moloney, A C %D 1997 %J Communicable Disease Report. CDR Review %K Adolescent, Adult, Age Aged, Child, Collection, Data Distribution, Factors, Female, Humans, Incidence, Infant, Ireland, Male, Meningitis, Meningococcal, Middle Preschool, Rate Risk Sex Survival %N 1 %P R9--13 %T Meningococcal disease in the Republic of Ireland: 1995 %U http://www.ncbi.nlm.nih.gov/pubmed/9029872 %V 7 %X Two hundred and nine culture confirmed cases of meningococcal disease were reported in the Republic of Ireland in 1995, using a new laboratory based surveillance system. The reported rate of 5.9/100000 population is one of the highest in western Europe, but the rate differed widely between regions. Fifty-three per cent of cases were female. Half of the cases occurred in four months (January, February, March, and December). Nineteen cases (9\%) died. The highest age specific incidence was in infancy (under 1 year). Infections with serogroup B accounted for 105 cases (54\%) and serogroup C 87 cases (45\%). We estimate that up to 30\% of cases of meningococcal disease may be preventable when conjugate meningococcal group C vaccines become available, but cost benefit analyses will be required to determine how they should be employed.

@article{fogarty_meningococcal_1997, abstract = {Two hundred and nine culture confirmed cases of meningococcal disease were reported in the Republic of Ireland in 1995, using a new laboratory based surveillance system. The reported rate of 5.9/100000 population is one of the highest in western Europe, but the rate differed widely between regions. Fifty-three per cent of cases were female. Half of the cases occurred in four months {(January,} February, March, and December). Nineteen cases (9\%) died. The highest age specific incidence was in infancy (under 1 year). Infections with serogroup B accounted for 105 cases (54\%) and serogroup C 87 cases (45\%). We estimate that up to 30\% of cases of meningococcal disease may be preventable when conjugate meningococcal group C vaccines become available, but cost benefit analyses will be required to determine how they should be employed.}, added-at = {2011-03-11T10:05:34.000+0100}, author = {Fogarty, I and Cafferkey, M T and Moloney, A C}, biburl = {https://www.bibsonomy.org/bibtex/27b266d68d8b18f386ee231bd2df7424d/jelias}, interhash = {2f7b524aec79ee3971c6b8ea2b674e92}, intrahash = {7b266d68d8b18f386ee231bd2df7424d}, issn = {1350-9349}, journal = {Communicable Disease Report. {CDR} Review}, keywords = {Adolescent, Adult, Age Aged, Child, Collection, Data Distribution, Factors, Female, Humans, Incidence, Infant, Ireland, Male, Meningitis, Meningococcal, Middle Preschool, Rate Risk Sex Survival}, month = jan, note = {{PMID:} 9029872}, number = 1, pages = {R9--13}, shorttitle = {Meningococcal disease in the Republic of Ireland}, timestamp = {2011-03-11T10:06:02.000+0100}, title = {Meningococcal disease in the Republic of Ireland: 1995}, url = {http://www.ncbi.nlm.nih.gov/pubmed/9029872}, volume = 7, year = 1997 }